YS Biopharma Co., Ltd. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
Q2 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
Q3 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
Q4 2024 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q1 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
YS Biopharma Co., Ltd. Earnings Date And Information
YS Biopharma Co., Ltd. last posted its earnings results on Friday, April 19th, 2024. The company reported $-0.12 earnings per share for the quarter, missing analysts' consensus estimates of $-0.08 by $0.04. The company had revenue of 164.98 M for the quarter and had revenue of 687.20 M for the year. YS Biopharma Co., Ltd. has generated $-2 earnings per share over the last year ($-1.56 diluted earnings per share) and currently has a price-to-earnings ratio of -2.21. YS Biopharma Co., Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 20th, 2024 based on prior year's report dates.
YS Biopharma Co., Ltd. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
01/22/2024 | Q3 2024 | -$0.72 | -$0.84 | -0.12 | $20.11 M | $164.98 M |
09/29/2023 | Q2 2024 | -$1.13 | $168.62 M | $96.82 M | ||
06/29/2023 | Q1 2024 | -$0.75 | $176.27 M | |||
12/30/2022 | Q3 2023 | -$0.86 | $181.65 M | |||
09/29/2022 | Q2 2023 | $0.09 | $194.06 M | |||
06/29/2022 | Q1 2023 | -$0.21 | $205.48 M |
YS Biopharma Co., Ltd. Earnings: Frequently Asked Questions
-
When is YS Biopharma Co., Ltd.'s earnings date?
YS Biopharma Co., Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 20th, 2024 based off last year's report dates.
-
How can I listen to YS Biopharma Co., Ltd.'s earnings conference call?
The conference call for YS Biopharma Co., Ltd.'s latest earnings report can be listened to online.
-
How can I read YS Biopharma Co., Ltd.'s conference call transcript?
The conference call transcript for YS Biopharma Co., Ltd.'s latest earnings report can be read online.
-
How much revenue does YS Biopharma Co., Ltd. generate each year?
YS Biopharma Co., Ltd. (:YS) has a recorded annual revenue of $687.20 M.
-
How much profit does YS Biopharma Co., Ltd. generate each year?
YS Biopharma Co., Ltd. (:YS) has a recorded net income of $687.20 M. YS Biopharma Co., Ltd. has generated $-1.56 earnings per share over the last four quarters.
-
What is YS Biopharma Co., Ltd.'s price-to-earnings ratio?
YS Biopharma Co., Ltd. (:YS) has a price-to-earnings ratio of -2.21 and price/earnings-to-growth ratio is 0.